RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist
- Research Organization:
- Brookhaven National Lab. (BNL), Upton, NY (United States)
- Sponsoring Organization:
- USDOE SC OFFICE OF SCIENCE (SC)
- DOE Contract Number:
- DE-AC02-98CH10886
- OSTI ID:
- 1162845
- Report Number(s):
- BNL-106791-2014-JA
- Journal Information:
- PLoS One, Vol. 8, Issue 12
- Country of Publication:
- United States
- Language:
- English
Similar Records
Structure-Guided Design of Potent Diazobenzene Inhibitors for the BET Bromodomains
Discovery of N -(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1 H -pyrrolo[2,3- c ]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor
Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9 H -pyrimido[4,5- b ]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor
Journal Article
·
Thu Nov 28 00:00:00 EST 2013
· Journal of Medicinal Chemistry
·
OSTI ID:1162845
+6 more
Discovery of N -(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1 H -pyrrolo[2,3- c ]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor
Journal Article
·
Thu Oct 12 00:00:00 EDT 2017
· Journal of Medicinal Chemistry
·
OSTI ID:1162845
+29 more
Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9 H -pyrimido[4,5- b ]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor
Journal Article
·
Tue May 02 00:00:00 EDT 2017
· Journal of Medicinal Chemistry
·
OSTI ID:1162845
+13 more